Latest filing published 18 Feb 2025 for C4 Therapeutics, Inc., €6,574.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jolie Siegel: trading record in brief
Jolie Siegel (senior executive) discloses dealings in 2 companies, chiefly C4 Therapeutics, Inc. and Neon Therapeutics, Inc. The record holds 26 filings, for trades running from 27 February 2019 to 14 February 2025.
On the market, this insider has only sold: 2 sales, €1.0M in total. Outside the open market, there are 16 share grants and 7 option exercises.
The record was last updated on 18 February 2025 with a share grant in C4 Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jolie Siegel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,135 shares@ US$3.202.8% of flowCommon StockSEC:0001662579-25-000020:0
- 3,750 sharesCommon StockSEC:0001662579-24-000101:0
- 2,250 sharesCommon StockSEC:0001662579-24-000079:0
- 1,735 shares@ US$6.534.5% of flowCommon StockSEC:0001662579-24-000018:0
- 2,250 sharesCommon StockSEC:0001662579-23-000085:0
- 20,000 shares0Common StockSEC:0001662579-23-000038:0
- 3,750 sharesCommon StockSEC:0001662579-23-000019:0
- 1,102 shares@ US$7.015.6% of flowCommon StockSEC:0001209191-22-036718:0
- 3,750 sharesCommon StockSEC:0001209191-22-032515:0
- 12,500 shares@ US$4.9840.7% of flowCommon StockSEC:0001209191-21-055881:0
- 12,500 shares@ US$4.9840.5% of flowCommon StockSEC:0001209191-21-049120:0
11 of 11 declarations
